PTCT R&D to Revenue
Ptc Therapeutics Inc · R&D to Revenue
PTCT R&D to Revenue
Latest reported26.31%period ending
PTCT FY R&D/Revenue (59.29% → 26.31%)
Latest values, visible window
High-resolution chart · PNG
PTCT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 26.305% | |
| 66.2485% | |
| 71.0756% | |
| 93.2305% | |
| 100.3882% | |
| 125.4427% | |
| 83.866% | |
| 64.9648% | |
| 60.4222% | |
| 142.232% | |
| 331.3279% | |
| 347.6811% | |
| 175.1738% | |
| 160.3209% | |
| 59.2932% |